Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tomas Rivero Equiza
Observed names:
Rivero Equiza Tomas,
T. Rivero Equiza,
Tomas Equiza Rivero,
Tomás Rivero Equiza
Institutions:
Josep Carreras Leukaemia Research Institute,
Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno,
Hospital Universitari Germans Trias i Pujol
Observed institutions:
Josep Carreras Leukaemia Research Institute,
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia,
Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno,
Sanatorio Otamendi y Miroli,
Hospital Universitari Germans Trias i Pujol
ORCID:
0000-0003-3266-8155
Observed ORCID:
0000-0003-3266-8155
OpenAlex ID:
A5066023832
Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March–June 2020
2020
·
Lucila M. Carosella
, Daniel Pryluka
, et al.
·
Emerging infectious diseases
·
48
PDF
Regulatory B Cells, Helminths, and Multiple Sclerosis
2014
·
Jorge Correale
, Tomas Rivero Equiza
·
Methods in molecular biology
·
15
Disease presentation and immunophenotype characteristics in 257 patients with blastic plasmacytoid dendritic cell neoplasm: A pethema/PALG study
2025
·
Beatriz Martín Herreros
, Irene Navarro Vicente
, et al.
·
Blood
·
1
Acute disseminated intravascular coagulation secondary to 177Lu-DOTATATE treatment in neuroendocrine tumor patients
2022
·
M.F. Illia
, M. Greco
, et al.
·
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
·
1
CNS prophylaxis in patients with DLBCL: Lymphoma Subcommittee of the Argentinian Society of Hematology experience
2025
·
Fernando Warley
, Patricio Pereyra
, et al.
·
Blood Global Hematology
Prognostic implications of commutational patterns in NPM1-mutated AML receiving intensive treatment. cetlam group study
2025
·
Paula Rodriguez Galvez
, Marcos Rivada Domínguez
, et al.
·
Blood
POSTER: MM-347 Are There Any Biological and Clinical Differences Between IgA Kappa and Lambda Multiple Myeloma? Experience From a Single Argentinian Center
2025
·
Victoria Giagame
, Tomás Rivero Equiza
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MM-347: Are There Any Biological and Clinical Differences Between IgA Kappa and Lambda MultipleMyeloma? Experience From a Single Argentinian Center
2025
·
Victoria Giagame
, Tomás Rivero Equiza
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-592 Treatment of Acute Myeloid Leukemia With Venetoclax-Based Combinations in Argentina: A Real-World Study
2024
·
Tomas Rivero Equiza
, Nicolas Cazap
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Treatment of Acute Myeloid Leukemia With Venetoclax-Based Combinations in Argentina: A Real-World Study
2024
·
Tomas Rivero Equiza
, Nicolas Cazap
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Cns Prophylaxis in Patients With Dlbcl: a Real World Experience on Behalf of the Lymphoma Subcommittee of the Argentine Society of Hematology
2023
·
F. Warley
, P. Pereyra
, et al.
·
Hematological Oncology
PDF
Analysis of 206 oncohematological patients admitted to the intensive care unit
2022
·
Antelo Guadalupe
, Cosacow Cesar
, et al.
·
Hematology & Transfusion International Journal
PDF
Coagulación intravascular diseminada secundaria a tratamiento con 177Lu-DOTATATE en paciente con tumor neuroendocrino
2022
·
M.F. Illia
, M. Greco
, et al.
·
Revista Española de Medicina Nuclear e Imagen Molecular
Poster: AML-005 Analysis of 206 Oncohematological Patients Admitted to the Intensive Care Unit
2022
·
Guadalupe Antelo Perez
, Cesar Cosacow
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-005 Analysis of 206 Oncohematological Patients Admitted to the Intensive Care Unit
2022
·
Guadalupe Antelo Perez
, Cesar Cosacow
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
15
Citation count:
65
H-index:
2
I10-index:
2
Year
Topic
Type